Abstract:

Purpose: Patients with immune system pressure are at risk of occasional intestinal parasite infections. This study aims to study the presence of enterocytozoon bieneusi and encephalitozoon intestinalis and other intestinal protozoons in the output samples of patients with immune system. Methods: Examples of ejaculation were taken from a total of 100 patients with chemotherapy or hematological malignity due to solid organ tumor, immunosuppressive treatment due to rheumatoid diseases, transplanted organs and being treated due to HIV infection. Excerption samples have been studied by the nativ-lugol method, excerption concentration, modified Kinyoun acid-fast and trichrom coloring methods, and the presence of protozoons has been studied. Excerption samples have also been studied in terms of the presence of Enterocytozoon bieneusi and Encephalitozoon intestinalis using the indirect fluorescent antibodies method. Results: In 12% of patients, one or more intestinal protozoons were detected. The distribution of intestinal protozoons is 7% Blastocystis spp, 2% Blastocystis spp. Dientamoeba fragilis, 1% Blastocystis spp. + Entamoeba coli, 1% Blastocystis spp. Giardia is intestinalis and 1% G intestinalis. The microsporidia spp. The IFA method was determined by 4% and 8% of calkoflor coloring. The result: In our study, the most detected intestinal protozoon in immunosuppressive patients is Blastocystis spp. The pathogenity of the types of Blastocystis is still controversial, and the role in immunosuppressive patients is not exactly known. Although these rates in our study are similar to prevalence in normal society, the importance of these microorganisms in patients with immunity system is important in terms of research, morbidity and reduction of mortality.

Keywords: